PALATINE, IL -- (Marketwire) -- 11/06/12 -- Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse, announced today financial results for the three and nine months ended September 30, 2012 .
PALATINE, IL--(Marketwire - Nov 1, 2012) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs , today announced that the company plans to report financial results for the third quarter of 2012 following the close of financial markets on
Acura Pharmaceuticals Announces Earlier Return of Development Products PALATINE, IL--(Marketwire - Sep 26, 2012) - Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR ), a specialty pharmaceutical company developing products intended to address medication abuse and misuse , announced today a letter
Acura Pharmaceuticals Announces Paragraph IV ANDA Filing for OXECTA(R) PALATINE, IL--(Marketwire - Sep 20, 2012) - Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR ), a specialty pharmaceutical company developing products intended to address medication abuse and misuse , today announced that it
Acura Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference on September 5, 2012 PALATINE, IL--(Marketwire -08/22/12)- Acura Pharmaceuticals, Inc. ( ACUR ), a specialty pharmaceutical company developing products intended to address medication abuse and misuse , announced today
Facebook
LinkedIn
Twitter